| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brief Reviews |
From the Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, Calif.
Correspondence to I. Jialal, MD, PhD, Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, 4635 2nd Ave, Research Bldg 1, Room 3000, Sacramento, CA 95817. E-mail ishwarlal.jialal{at}ucdmc.ucdavis.edu
Series Editor: Margo Denke
Nutrition and Atherosclerosis
ATVB In Focus
Previous Brief Reviews in this Series:
Isganaitis E, Lustig RH. Fast food, central nervous system insulin resistance, and obesity. 2005;25:24512462.
Levine JA, Vander Weg MW, Hill JO, Klesges RC. Non-exercise activity thermogenesis: the crouching tiger hidden dragon of societal weight gain. 2006;26:729736.
Inflammation plays a pivotal role in all stages of atherosclerosis. Cardiovascular risk factors and metabolic syndrome are typified by low-grade inflammation. Intervention trials convincingly demonstrate that weight loss reduces biomarkers of inflammation, such as C-reactive protein (CRP) and interleukin (IL)-6. Limited studies have shown that certain dietary factors; oleic acid,
-linolenic acid, and antioxidants RRR-
-alpha tocopherol, reduce biomarkers of inflammation. Most of the studies with fish oil supplementation have shown null effects, and conflicting results have been reported with saturated and trans fatty acids, cholesterol, and soy intake. Much further research is needed to define the role of individual dietary factors on the biomarkers of inflammation and the mechanism of the anti-inflammatory effects of weight loss.
Inflammation is pivotal in atherosclerosis. Weight loss appears to be the best modality to reduce inflammation. Individual dietary factors responsible for the effects of weight loss on inflammation need to be better defined.
Key Words: C-reactive protein diet inflammation macronutrients micronutrients weight loss
This article has been cited by other articles:
![]() |
T. E. Weber, C. J. Ziemer, and B. J. Kerr Effects of adding fibrous feedstuffs to the diet of young pigs on growth performance, intestinal cytokines, and circulating acute-phase proteins J Anim Sci, April 1, 2008; 86(4): 871 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kan, J. Stevens, G. Heiss, K. M. Rose, and S. J. London Dietary Fiber, Lung Function, and Chronic Obstructive Pulmonary Disease in the Atherosclerosis Risk in Communities Study Am. J. Epidemiol., March 1, 2008; 167(5): 570 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. DeLegge and A. Smoke Neurodegeneration and Inflammation Nutr Clin Pract, February 1, 2008; 23(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, R. MacDonald, D. Bruemmer, A. Stromberg, A. Daugherty, X.-a. Li, M. Toborek, and B. Hennig Zinc Deficiency Alters Lipid Metabolism in LDL Receptor Deficient Mice Treated with Rosiglitazone J. Nutr., November 1, 2007; 137(11): 2339 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jarvenpaa, R. L. Tahvonen, A. C. Ouwehand, M. Sandell, E. Jarvenpaa, and S. Salminen A Probiotic, Lactobacillus fermentum ME-3, Has Antioxidative Capacity in Soft Cheese Spreads with Different Fats J Dairy Sci, July 1, 2007; 90(7): 3171 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Nettleton, L. M Steffen, M. B Schulze, N. S Jenny, R G. Barr, A. G Bertoni, and D. R Jacobs Jr Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1615 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. King, B. M. Egan, R. F. Woolson, A. G. Mainous III, Y. Al-Solaiman, and A. Jesri Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level Arch Intern Med, March 12, 2007; 167(5): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lawson, S. Kim, W. S. Powell, G. A. FitzGerald, and J. Rokach Oxidized derivatives of {omega}-3 fatty acids: identification of IPF3{alpha}-VI in human urine J. Lipid Res., November 1, 2006; 47(11): 2515 - 2524. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |